ERBB2 and breast carcinoma: Furthermore GPER has been assessed in 323 breast cancer patients with a validation cohort of 103 patients to show associations between GPER expression and lymph node status, and HER2 status; this study also demonstrated an association between high GPER expression and adverse relapse free survival but no association was observed for overall survival [17].